Physician profile
Nicholas Abend
NPI 1679638969
$55,939.71
in general payments reported to CMS, 2019-2025
11 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $28.42 · 2021: $4,841 · 2022: $2,949 · 2023: $7,206 · 2024: $26K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Travel and Lodging: $3,450 · Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,155.00 |
| Travel and Lodging | $3,449.95 |
| Food and Beverage | $1,376.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $36,759.51 | 2021-2025 | Briviact, Nayzilam |
| Ceribell, INC. | $13,958.83 | 2023-2025 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Btg International INC. | $2,734.12 | 2022 | |
| Natus Medical Incorporated | $1,000.00 | 2021 | |
| Hikma Pharmaceuticals USA | $1,000.00 | 2021 | |
| Jazz Pharmaceuticals INC. | $214.76 | 2022 | |
| Greenwich Biosciences, INC. | $140.07 | 2019 | |
| Neurelis, INC. | $104.00 | 2024 | Valtoco |
| Eisai INC. | $28.42 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Abend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.